{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T16:34:01Z","timestamp":1778776441092,"version":"3.51.4"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:00:00Z","timestamp":1747180800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Valproic acid (VPA) constitutes a branched-chain, short-chain fatty acid that serves as an antiepileptic medication. It has been increasingly recognized that VPA has presented potential anti-tumor properties, including breast cancer. However, the exploration of novel breast cancer treatment methods necessitates a more comprehensive and in-depth understanding of the novel mechanism of VPA inhibition of breast cancer. It has been proven that farnesyl-diphosphate farnesyltransferase 1 (FDFT1) participate in oncogenesis and development of cancers. However, the effect of FDFT1 on breast cancer is still obscure. Thus, it is important to investigate the potential of VPA to trigger ferroptosis in breast cancer cells via targeting FDFT1.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In this study, the underlying mechanisms of VPA on ferroptosis in breast cancer cells were explored in vitro and vivo. Initially, the effects of VPA on the proliferation of breast cancer cells were assessed utilizing the Cell Counting Kit-8, cell counting, and colony formation assays. Subsequently, the ferroptosis in breast cancer cells treated with VPA were determined through the use of the Lipid Peroxidation malondialdehyde Assay Kit, reduced glutathione and oxidized glutathione disulfide Assay Kit, flow cytometry, transmission electron microscopy, and western bloting. To explore the impact of VPA in combination with ferrostatin-1, Erastin or RSL3, on MDA-MB-231 cell proliferation and ferroptosis, respective CCK-8, colony formation and WB assays were conducted. Thereafter, we assessed whether VPA facilitated ferroptosis in MDA-MB-231 cells by modulating the expression of FDFT1. Finally, the anti-breast cancer effects of VPA in vivo were validated through a xenograft mouse model, and histological examination via hematoxylin-eosin staining and immunohistochemistry staining were employed to delve into the underlying mechanisms of VPA\u2019s inhibitory effects on breast cancer cells in vivo.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results and Discussion<\/jats:title><jats:p>The assay outcomes indicated that VPA impedes the proliferation of breast cancer cells. The findings from the ferroptosis index demonstrated that MDA-MB-231 cells are more sensitive to VPA induced ferroptosis than MCF-7 cells. Subsequent to the introduction of ferrostatin-1 (Fer-1), Erastin or RSL3, it was observed that Fer-1 reversed the ferroptosis facilitated by VPA, whereas Erastin or RSL3, in conjunction with VPA, respectively, induced ferroptosis in MDA-MB-231 cells. We revealed that the downregulation of FDFT1 enhanced proliferation and inhibited ferroptosis of MDA-MB-231 cells. Additionally, we discovered that VPA may facilitate ferroptosis in MDA-MB-231 cells by negatively modulating the levels of the solute carrier family 7 member 11 (SLC7A11) protein through the upregulation of FDFT1 expression. In conclusion, this study elucidated that VPA induced the ferroptosis of MDA-MB-231 cells via targeting FDFT1, representing a novel mechanism underlying its efficacy in potentially inhibiting breast cancer.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fphar.2025.1540667","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T05:38:08Z","timestamp":1747201088000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Valproic acid induces ferroptosis and suppresses the proliferation of MDA-MB-231 cells by targeting FDFT1"],"prefix":"10.3389","volume":"16","author":[{"given":"Shuxian","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiazhuo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yisong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ran","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingzhi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuangping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,5,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.ijrobp.2013.02.012","article-title":"Valproic acid use during radiation therapy for glioblastoma associated with improved survival","volume":"86","author":"Barker","year":"2013","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"B2","doi-asserted-by":"publisher","first-page":"18777","DOI":"10.1074\/jbc.M611763200","article-title":"Squalene synthase, a determinant of Raft-associated cholesterol and modulator of cancer cell proliferation","volume":"282","author":"Brusselmans","year":"2007","journal-title":"J. Biol. Chem."},{"key":"B3","doi-asserted-by":"publisher","first-page":"e2411719","DOI":"10.1002\/advs.202411719","article-title":"Targeting FDFT1 reduces cholesterol and bile acid production and delays hepatocellular carcinoma progression through the HNF4A\/ALDOB\/AKT1 Axis","volume":"12","author":"Cai","year":"2025","journal-title":"Adv. Sci. (Weinh)"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1007\/s00018-016-2194-1","article-title":"Mechanisms of ferroptosis","volume":"73","author":"Cao","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"key":"B5","doi-asserted-by":"publisher","first-page":"121954","DOI":"10.1016\/j.lfs.2023.121954","article-title":"FDFT1 repression by piR-39980 prevents oncogenesis by regulating proliferation and apoptosis through hypoxia in tongue squamous cell carcinoma","volume":"329","author":"Chattopadhyay","year":"2023","journal-title":"Life Sci."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.1016\/S0140-6736(16)32454-0","article-title":"Molecular alterations in triple-negative breast cancer-the road to new treatment strategies","volume":"389","author":"Denkert","year":"2017","journal-title":"Lancet"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"B8","doi-asserted-by":"publisher","first-page":"120976","DOI":"10.1016\/j.lfs.2022.120976","article-title":"Valproic acid regulates MIEF1 through MST2-HIPPO to suppress breast cancer growth","volume":"309","author":"Du","year":"2022","journal-title":"Life Sci."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.2174\/0109298673377428250131112647","article-title":"Identification of ferroptosis-related prognostic models and FDFT1 as a potential ferroptosis driver in colorectal cancer","volume":"32","author":"Duan","year":"2025","journal-title":"Curr. Med. Chem."},{"key":"B10","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s11060-017-2672-9","article-title":"Toxic effects of phytol and retinol on human glioblastoma cells are associated with modulation of cholesterol and fatty acid biosynthetic pathways","volume":"136","author":"Facchini","year":"2018","journal-title":"J. Neurooncol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e2006203","DOI":"10.1371\/journal.pbio.2006203","article-title":"Unsolved mysteries: how does lipid peroxidation cause ferroptosis?","volume":"16","author":"Feng","year":"2018","journal-title":"PLoS Biol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1056\/NEJMra1001389","article-title":"Triple-negative breast cancer","volume":"363","author":"Foulkes","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.3390\/cells9112352","article-title":"Roles of farnesyl-diphosphate farnesyltransferase 1 in tumour and tumour microenvironments","volume":"9","author":"Ha","year":"2020","journal-title":"Cells"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1016\/S0140-6736(16)31891-8","article-title":"Breast cancer","volume":"389","author":"Harbeck","year":"2017","journal-title":"Lancet"},{"key":"B15","doi-asserted-by":"publisher","first-page":"3993","DOI":"10.1002\/cam4.4716","article-title":"Identification of FDFT1 as a potential biomarker associated with ferroptosis in ccRCC","volume":"11","author":"Huang","year":"2022","journal-title":"Cancer Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s00432-019-03118-4","article-title":"Histone deacetylase inhibitors dysregulate DNA repair proteins and antagonize metastasis-associated processes","volume":"146","author":"Kiweler","year":"2020","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1002\/dneu.22359","article-title":"Valproic acid stimulates proliferation of glial precursors during cortical gliogenesis in developing rat","volume":"76","author":"Lee","year":"2016","journal-title":"Dev. Neurobiol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1111\/jcmm.17124","article-title":"Recent advances of transcriptomics and proteomics in triple-negative breast cancer prognosis assessment","volume":"26","author":"Li","year":"2022","journal-title":"J. Cell Mol. Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"9636897211027524","DOI":"10.1177\/09636897211027524","article-title":"Valproic acid suppresses breast cancer cell growth through triggering pyruvate kinase M2 isoform mediated warburg effect","volume":"30","author":"Li","year":"2021","journal-title":"Cell Transpl."},{"key":"B20","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/s41419-025-07555-7","article-title":"Male-specific lethal 1 (MSL1) promotes Erastin-induced ferroptosis in colon cancer cells by regulating the KCTD12-SLC7A11 axis","volume":"16","author":"Luo","year":"2025","journal-title":"Cell. death. Dis."},{"key":"B21","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13045-019-0720-y","article-title":"Ferroptosis, a new form of cell death: opportunities and challenges in cancer","volume":"12","author":"Mou","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.bbrc.2021.03.049","article-title":"Ubiquitin specific peptidase 32 acts as an oncogene in epithelial ovarian cancer by deubiquitylating farnesyl-diphosphate farnesyltransferase 1","volume":"552","author":"Nakae","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B23","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s11060-008-9732-0","article-title":"Synergistic induction of NY-ESO-1 antigen expression by a novel histone deacetylase inhibitor, valproic acid, with 5-aza-2'-deoxycytidine in glioma cells","volume":"92","author":"Oi","year":"2009","journal-title":"J. Neurooncol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"63","DOI":"10.4103\/abr.abr_142_19","article-title":"Histone deacetylases and histone deacetylase inhibitors: molecular mechanisms of action in various cancers","volume":"8","author":"Sanaei","year":"2019","journal-title":"Adv. Biomed. Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"711776","DOI":"10.3389\/fonc.2021.711776","article-title":"An original ferroptosis-related gene signature effectively predicts the prognosis and clinical status for colorectal cancer patients","volume":"11","author":"Shao","year":"2021","journal-title":"Front. Oncol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","article-title":"Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease","volume":"171","author":"Stockwell","year":"2017","journal-title":"Cell"},{"key":"B27","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.tcb.2020.02.009","article-title":"Emerging mechanisms and disease relevance of ferroptosis","volume":"30","author":"Stockwell","year":"2020","journal-title":"Trends Cell Biol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"B29","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/s1388-1981(00)00137-2","article-title":"Structure and regulation of mammalian squalene synthase","volume":"1529","author":"Tansey","year":"2000","journal-title":"Biochim. Biophys. Acta."},{"key":"B30","doi-asserted-by":"publisher","first-page":"15020","DOI":"10.3390\/ijms241915020","article-title":"3\u03b2-Hydroxy-12-oleanen-27-oic acid exerts an antiproliferative effect on human colon carcinoma HCT116 cells via targeting FDFT1","volume":"24","author":"Tu","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B31","doi-asserted-by":"publisher","first-page":"51","DOI":"10.2217\/pme-2016-0058","article-title":"Characterization of farnesyl diphosphate farnesyl transferase 1 (FDFT1) expression in cancer","volume":"16","author":"Tuzmen","year":"2025","journal-title":"Med"},{"key":"B32","doi-asserted-by":"publisher","first-page":"102396","DOI":"10.1016\/j.tranon.2025.102396","article-title":"Targeting FASN enhances cisplatin sensitivity via SLC7A11-mediated ferroptosis in cervical cancer","volume":"56","author":"Wang","year":"2025","journal-title":"Transl. Oncol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"148498","DOI":"10.1016\/j.gene.2024.148498","article-title":"Identification of the ferroptosis-related prognostic gene signature in mesothelioma","volume":"919","author":"Wang","year":"2024","journal-title":"Gene"},{"key":"B34","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.lfs.2010.12.017","article-title":"Inhibitory effects of the HDAC inhibitor valproic acid on prostate cancer growth are enhanced by simultaneous application of the mTOR inhibitor RAD001","volume":"88","author":"Wedel","year":"2011","journal-title":"Life Sci."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1038\/s41467-020-15795-8","article-title":"Fasting inhibits aerobic glycolysis and proliferation in colorectal cancer via the Fdft1-mediated AKT\/mTOR\/HIF1\u03b1 pathway suppression","volume":"11","author":"Weng","year":"2020","journal-title":"Nat. Commun."},{"key":"B36","first-page":"3659","article-title":"Differences of ferroptosis-related genes between White and Asian patients with liver cancer","volume":"13","author":"Xia","year":"2022","journal-title":"Am. J. Cancer Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/cdd.2015.158","article-title":"Ferroptosis: process and function","volume":"23","author":"Xie","year":"2016","journal-title":"Cell Death Differ."},{"key":"B38","doi-asserted-by":"publisher","first-page":"4900","DOI":"10.1111\/jcmm.14511","article-title":"Molecular mechanisms of ferroptosis and its role in cancer therapy","volume":"23","author":"Xu","year":"2019","journal-title":"J. Cell Mol. Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41392-020-00428-9","article-title":"Ferroptosis: mechanisms and links with diseases","volume":"6","author":"Yan","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"B40","doi-asserted-by":"publisher","first-page":"971364","DOI":"10.3389\/fgene.2022.971364","article-title":"A ferroptosis associated gene signature for predicting prognosis and immune responses in patients with colorectal carcinoma","volume":"13","author":"Yan","year":"2022","journal-title":"Front. Genet."},{"key":"B41","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1164\/rccm.201404-0714OC","article-title":"Squalene synthase induces tumor necrosis factor receptor 1 enrichment in lipid rafts to promote lung cancermetastasis","volume":"190","author":"Yang","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1111\/jcmm.13008","article-title":"Ferroptosis, a new form of cell death, and its relationships with tumourous diseases","volume":"21","author":"Yu","year":"2017","journal-title":"J. Cell Mol. Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"217726","DOI":"10.1016\/j.canlet.2025.217726","article-title":"SIK1 promotes ferroptosis resistance in pancreatic cancer via HDAC5-STAT6-SLC7A11 axis","volume":"623","author":"Zhang","year":"2025","journal-title":"Cancer Lett."},{"key":"B44","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s11010-011-1085-x","article-title":"VPA inhibits breast cancer cell migration by specifically targeting HDAC2 and down-regulating Survivin","volume":"361","author":"Zhang","year":"2012","journal-title":"Mol. Cell. Biochem."},{"key":"B45","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1186\/s12935-021-02416-7","article-title":"Glucose starvation suppresses gastric cancer through targeting miR-216a-5p\/Farnesyl-Diphosphate Farnesyltransferase 1 axis","volume":"21","author":"Zhao","year":"2021","journal-title":"Cancer Cell Int."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1540667\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T05:38:09Z","timestamp":1747201089000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1540667\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,14]]},"references-count":45,"alternative-id":["10.3389\/fphar.2025.1540667"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1540667","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,14]]},"article-number":"1540667"}}